FDA Inspection
WuXi Advanced TherapiesWuXi Advanced Therapies – FDA Inspection, Jan 22, 2020
Record Details
This FDA Inspection record concerns WuXi Advanced Therapies, with an inspection on January 22, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- WuXi Advanced Therapies
- Inspection Date
- January 22, 2020
- Product Type
- Drugs
View Company Profile
ID · 0a449cf5-20ff-4805-b457-1937e3622faa
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1121335
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of WuXi Advanced Therapies
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 25, 2025 | Not classified | Philadelphia District Office | |
| February 7, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 1, 2023 | Not classified | Philadelphia District Office | |
| April 17, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for WuXi Advanced Therapies
- FDA Inspection 1299454 - 2025-11-25
- FDA Inspection 1262215 - 2025-02-07
- FDA Inspection 1230154 - 2023-09-01
- FDA Inspection 921995 - 2015-04-17
- FDA Inspection 849366 - 2013-09-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.